Bramacare has opened a new facility in Ipswich offering supported living for adults recovering from complex eating disorders, ...
Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral ...
Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral ...
The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of ...
Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital ...
Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital ...
Cori Clinical has announced the appointment of Dr Emma Ogburn as Chief Clinical Officer. She joins Cori’s founding team of ...
The first 90 days after starting antipsychotic treatment are a critical period for monitoring blood glucose and weight, ...
But these functions often work separately, leaving HCPs with disjointed experiences rather than interactions that build on ...
A digital platform for exchanging pharmaceutical quality records between supply-chain partners is now commercially available, following an Innovate UK-funded ...
The UK may face increasing pressure to secure long-term supplies of immunoglobulin (Ig), with rising demand and heavy ...
Claris Biotherapeutics has reported visual acuity improvements with its experimental therapy CSB-001 in a proof-of-concept study involving patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results